Covea Finance Zoetis Inc. Transaction History

Covea Finance

$2.27 Billion
Q3 2024

A detailed history of Covea Finance transactions in Zoetis Inc. stock. As of the latest transaction made, Covea Finance holds 256,444 shares of ZTS stock, worth $42.2 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

256,444

Previous 207,444 23.62%

Holding current value

$42.2 Million

Previous $36 Million 39.32%

% of portfolio

2.21%

Previous 1.65%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$172.58 - $196.48 $8.46 Million - $9.63 Million	49,000 Added 23.62%	256,444 $50.1 Million
Q2 2024 Jul 16, 2024	SELL	$145.54 - $178.83 $5.83 Million - $7.17 Million	-40,083 Reduced 16.19%	207,444 $36 Million
Q1 2024 Apr 19, 2024	SELL	$165.67 - $199.94 $463,378 - $559,232	-2,797 Reduced 1.12%	247,527 $41.9 Million
Q3 2023 Oct 10, 2023	BUY	$167.14 - $192.77 $2.39 Million - $2.75 Million	14,270 Added 6.05%	250,324 $43.6 Million
Q2 2023 Jul 07, 2023	BUY	$160.94 - $186.23 $2.82 Million - $3.27 Million	17,537 Added 8.03%	236,054 $40.7 Million
Q1 2023 Apr 17, 2023	SELL	$145.48 - $175.02 $26.1 Million - $31.5 Million	-179,697 Reduced 45.13%	218,517 $36.4 Million
Q4 2022 Feb 02, 2023	BUY	$131.14 - $157.47 $26.1 Million - $31.4 Million	199,107 Added 100.0%	398,214 $58.7 Million
Q2 2022 Jul 22, 2022	SELL	$155.97 - $200.09 $2.2 Million - $2.82 Million	-14,110 Reduced 6.62%	199,107 $34.2 Million
Q1 2022 Apr 26, 2022	SELL	$181.39 - $234.03 $6.17 Million - $7.96 Million	-34,004 Reduced 13.75%	213,217 $40.2 Million
Q4 2021 Feb 09, 2022	BUY	$193.69 - $247.03 $47.9 Million - $61.1 Million	247,221 New	247,221 $60.3 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covea Finance, based on Form 13F filings with the SEC.

News

Stay updated on Covea Finance with notifications on news.

Account